VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 732 filers reported holding VANECK VECTORS ETF TR in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,151,405 | +9.4% | 42,787 | +22.4% | 0.01% | -43.8% |
Q2 2023 | $1,052,473 | -67.4% | 34,954 | -65.0% | 0.02% | -69.2% |
Q1 2023 | $3,231,613 | -75.1% | 99,895 | -50.5% | 0.05% | -53.2% |
Q4 2022 | $12,973,972 | +156.9% | 201,704 | -3.7% | 0.11% | +141.3% |
Q3 2022 | $5,050,634 | +81.8% | 209,428 | +106.4% | 0.05% | -24.6% |
Q2 2022 | $2,777,810 | -26.7% | 101,444 | +2.7% | 0.06% | -30.7% |
Q1 2022 | $3,792,000 | +19.8% | 98,787 | 0.0% | 0.09% | +11.4% |
Q4 2021 | $3,165,000 | -8.6% | 98,787 | -15.9% | 0.08% | -21.8% |
Q3 2021 | $3,461,000 | +15.4% | 117,501 | +33.2% | 0.10% | +12.2% |
Q2 2021 | $2,999,000 | +6.3% | 88,238 | +1.7% | 0.09% | -5.3% |
Q1 2021 | $2,820,000 | -9.8% | 86,763 | 0.0% | 0.10% | -25.8% |
Q4 2020 | $3,125,000 | +2665.5% | 86,763 | +2894.9% | 0.13% | +966.7% |
Q3 2020 | $113,000 | -81.9% | 2,897 | -83.0% | 0.01% | -83.8% |
Q2 2020 | $623,000 | +59.3% | 17,000 | 0.0% | 0.07% | +32.1% |
Q1 2020 | $391,000 | – | 17,000 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |